Olstein: Three Names with More Room to Run

In this video segment with Morningstar editor Jason Stipp, Bob Olstein makes the case for Microsoft, Macy's, and Dr Pepper Snapple.

Olstein: Large-Cap Quality Still on Sale

In this video segment with Morningstar editor Jason Stipp, Bob Olstein discusses how certain companies still look attractive in light of their safety, dividend yields, and competitive advantages.

Four Reasons to Fill Up on Dr. Pepper Snapple

Bob Olstein discusses the unrecognized value in Dr. Pepper Snapple Group in Fortune's Anatomy of a Trade feature.

Macy's Biggest Bargain: It's Shares

Bob Olstein discusses Macy's ability to generate free cash flow in Barron's profile of the retailer's operating turnaround.

Depreciation: An Appreciation

Bob Olstein and Eric Heyman discuss how depreciation, as reported to shareholders, can overstate or understate a company's cash earnings.

Accountable Investor

Morningstar profiles Bob Olstein in its "Ten Questions" feature.

James Glassman's 10 Picks for 2012

In his Opening Shot column, James Glassman highlights an Olstein holding, Ruby Tuesday, as one of his top ten stock picks for 2012


Investing involves risk including possible loss of principal.  Investors should carefully consider the investment objectives, risks, charges and expenses of the Olstein Funds.  This and other important information is contained in the prospectus, which should be read carefully before investing.  For a copy, click the prospectus link below.  

Past performance is no guarantee of future results. This information is not an offer to sell or a solicitation to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer, solicitation, purchase, or sale may not lawfully be made. Important legal information – please read the disclaimer before proceeding. Be sure to read the Olstein Funds Privacy Policy before becoming a shareholder. Click here to read the disclaimer+